The cost of preventing readmissions: why surgeons should lead the effort

Area of Science:

• Healthcare economics
• Hospital administration
• Patient outcomes

Background:

• The Affordable Care Act mandates Medicare financial penalties for hospitals exceeding 30-day readmission rates.
• Current penalties apply to specific conditions like myocardial infarction, heart failure, and pneumonia, capped at 1% of Medicare reimbursements.
• Future penalties (2015) will increase to 3% and include more surgical diagnoses, intensifying financial pressure on hospitals.

Purpose of the Study:

• To assess the cost-effectiveness of managing patients with 30-day readmissions after cardiac surgery.
• To compare the net hospital profit between readmission scenarios and hypothetical preventative outpatient management.
• To evaluate the financial impact of Medicare's readmission penalties on hospital profitability.

Main Methods:

• Retrospective review of adult cardiac surgery patients treated in 2012.
• Analysis of unplanned 30-day readmissions.
• Cost-efficiency calculation comparing readmission costs versus outpatient management feasibility.

Main Results:

• Out of 576 patients, 68 (11.8%) had unplanned 30-day readmissions.
• Outpatient management was feasible for 18 (26.5%) of readmitted patients.
• While readmissions showed a net profit of $144,000, Medicare penalties resulted in a net loss of $11,950.

Conclusions:

• Medicare's readmission penalty significantly impacts hospital finances, turning potential profits into losses.
• Readmission reduction programs costing over $11,950 annually would result in financial loss.
• Developing cost-effective strategies to reduce hospital readmissions is crucial to mitigate financial penalties.